Circulation collapse caused by intracardiac thrombosis associated with tranexamic acid administration: A case report

Medicine (Baltimore). 2021 Nov 24;100(47):e27997. doi: 10.1097/MD.0000000000027997.

Abstract

Rationale: Perioperative administration of tranexamic acid has been suggested to reduce bleeding and blood transfusion requirements in patients undergoing orthopedic surgery. Despite being sporadic, the potential risk for thrombotic complications cannot be ignored. However, intracardiac thrombosis associated with tranexamic acid administration is rare. We described a case of circulatory collapse caused by intracardiac thrombosis associated with tranexamic acid administration for a scheduled knee arthroplasty.

Patient concerns: A 62-year-old male patient was scheduled for a right knee arthroplasty. He had a history of hypertension and had undergone surgery for treatment of right femur fracture 30 years previously. Other than a high platelet count (498 × 109/L), results of laboratory investigations were within normal limits. The ultrasonic examination of both lower limbs showed no thrombosis. Upon sterilizing the surgical area, tranexamic acid (1.6 g) was intravenously administered after induction of anesthesia and intubation. Then the patient had a sudden circulatory collapse. Through cardiopulmonary resuscitation, the patient recovered spontaneous circulation. Transesophageal echocardiography revealed extensive thrombosis in the right atrium and ventricle.

Diagnosis: Circulation collapse caused by intracardiac thrombosis.

Interventions: Thrombolytic therapy was recommended after urgent multidisciplinary consultation. Thus, urokinase was administered intravenously. Fifty minutes after thrombolysis, the mass in ventricle disappeared. A shrunken mass was observed in the right atrium. After another half an hour, no abnormal echoes were seen in the right heart chambers.

Outcomes: The patient was discharged after 43 days without any organ dysfunction.

Lessons: This case reminds clinicians that perioperative tranexamic acid administration may increase the risk of thrombosis, which needs focused attention from anesthesiologists. Prompt transesophageal echocardiography examination should be done to allow immediate diagnosis and effective thrombolysis therapy when unexplained cardiac arrest occurs during anesthesia.

Publication types

  • Case Reports

MeSH terms

  • Antifibrinolytic Agents / administration & dosage
  • Antifibrinolytic Agents / adverse effects*
  • Arthroplasty, Replacement, Knee / methods*
  • Blood Circulation / drug effects*
  • Blood Loss, Surgical
  • Cardiopulmonary Resuscitation
  • Echocardiography, Transesophageal
  • Epinephrine / administration & dosage*
  • Humans
  • Injections, Intraventricular
  • Male
  • Middle Aged
  • Shock / etiology*
  • Thrombosis / chemically induced*
  • Thrombosis / diagnostic imaging
  • Tranexamic Acid / administration & dosage
  • Tranexamic Acid / adverse effects*

Substances

  • Antifibrinolytic Agents
  • Tranexamic Acid
  • Epinephrine